Arif Tanmoy

Genome enthusiast with little microbial knowledge. Love to code, but no bioinfo background. Associate Scientist at @chrfbd.
Have a house full of birds.

[Bloom Lab @jbloom_lab]

I wanted to summarize what is known about the new XBB.1.5 variant of SARS-CoV-2, which is starting to generate a lot of interest.

(There are no new scientific results in this thread, it simply aggregates previously reported results for those not following topic closely.)

[Arif Tanmoy @ariftanm]

Feeling proud to be a major part of this work. 😇😇😇
#Paratype #Paratyphoid

[Senjuti Saha, PhD | সেঁজুতি সাহা @senjutisaha]

Ending 2022 with @NatureComms article from Bangladesh describing "Paratype"! #Paratyphoid = tropical disease neglected globally, impeding genomic studies. We developed an open-access genotyping scheme, Paratype, to segregate #Salmonella #Paratyphi A.
https://t.co/P5tS5GFHNT
1/6

[Arif Tanmoy @ariftanm]

🥰🥰🥰

[Senjuti Saha, PhD | সেঁজুতি সাহা @senjutisaha]

We @chrfbd are excited to release open-access & easy-to-use tool ‘Paratype’ to support sequencing efforts for Salmonella Paratyphi A, etiology of paratyphoid fever, a neglected tropical disease.
👉 https://t.co/1447xYtsK5
Brainchild of @arif_tanmoy @yogihooda88 @SajibMSI
1/5

[Arif Tanmoy @ariftanm]

https://t.co/Ip6NANJZt3

[Arif Tanmoy @ariftanm]

THAT FEELING...when you forgot to read the manual of the tool that you wrote yourself months ago and the tool starts giving you huge errors (as you missed parts of the commands). AND you go insane...😋

[Arif Tanmoy @ariftanm]

😃😃😃

[Senjuti Saha, PhD | সেঁজুতি সাহা @senjutisaha]

Phages: my first love

A few crazy days (& nights) in the lab. But ended with beautiful sequencing results from our 1st batch of Salmonella bacteriophage library @chrfbd!

Phages, here we come! Enough of SARS-CoV-2, time for some viruses that kill bacteria!

#phages
#WomenInSTEM

[Arif Tanmoy @ariftanm]

This is great for typhoid-endemic tropical countries. TCV can remain stable for 7 days at 45C.

[Take on Typhoid @PreventTyphoid]

A recent study explored the stability of Typbar TCV outside of the cold chain prior to administration, finding that the vaccine remained stable for 7 days at 45˚C. ☀️
This would facilitate greater flexibility for vaccination campaigns to #TakeOnTyphoid. https://t.co/v2iJnFrhOq

[Senjuti Saha, PhD | সেঁজুতি সাহা @senjutisaha]

I had recently posted the idea of forming a beginners "runners club" for girls/women in Dhaka. The rapid & positive response have been amazing! If there is anyone here who is interested, please fill up this 1-min-form ASAP & we can hang! https://t.co/HmUYOwYnW5

[Arif Tanmoy @ariftanm]

Bangladesh Need Vaccines.
A portrayal of COVID-19 situation on its 3rd wave in Bangladesh.

From our fantastic @chrfbd team, led by @senjutisaha and @ChrfSaha. Congratz to all authors.
#VaccineEquity
#COVID19Vaccine
#DeltaVariant https://t.co/zyKGFIC85r

[Arif Tanmoy @ariftanm]

How indeed... 😑

[Arif Tanmoy @ariftanm]

#TakeOnTyphoid

[Take on Typhoid @PreventTyphoid]

TyVAC's phase 3 TCV trial in Mirpur, Dhaka, #Bangladesh enrolled 61,567 children 9m -16y. The cluster design approximated a real-world setting, so we can expect real-world use of TCV to see close to 85% reduction in disease. 📉 #VaccinesWork #TakeOnTyphoid
https://t.co/LHCKLPRZvR

[Zoe Anne Dyson @msmicrobiocode]

Phylogenomics and antimicrobial resistance of Salmonella Typhi and Paratyphi A, B and C in England, 2016–2019 | Microbiology Society https://t.co/K5hvUAn6aQ

[Arif Tanmoy @ariftanm]

Hey bacteria, need quick adaptation? Use your prophage.😋

Crazy bacterial world, when you use your killer phages to adapt yourself..

https://t.co/2V7wsLf0ot

[Arif Tanmoy @ariftanm]

Wow.. Tree of a million SARS-VoV-2 sequences...

[Theo Sanderson @theosanderson]

Introducing 🌳https://t.co/m8MusGFkpI: a new tool that lets you dive into a tree of more than a million public SARS-CoV-2 sequences from around the world.

Quick 🧵 below or just give it a try.

[ROTA Council @ROTACouncil]

📢🚨The updated @WHO Rotavirus Vaccine Position Paper is out now!

Replacing the previous 2013 position paper, this version incorporates two #rotavirus vaccines prequalified in 2018— ROTAVAC (@BharatBiotech) & ROTASIIL (@SerumInstIndia)

Read it here!➡️https://t.co/kflHT9zijI

[Senjuti Saha, PhD | সেঁজুতি সাহা @senjutisaha]

When I tested +ve for Covid19, I was stuck between being a patient & being a scientist working on Covid-19.

Thanks @LancetGH for publishing my/our story!

As upset as I am, it has provided with more ammunition for the fight against inequities in health.

https://t.co/2AZbDifPhu

[Arif Tanmoy @ariftanm]

This should be the message to our family, friends, relatives...everyone

[Ran Blekhman @blekhman]

Instead of saying "they got covid despite of being vaccinated", say "they got covid with only mild/no symptoms thanks to being vaccinated" 👍

[Arif Tanmoy @ariftanm]

Indeed...

[Abdullah Al Nahid @abdnahid_]

Now out my co-lead authored paper in @ASMicrobiology journal Microbiology Resource Announcements. https://t.co/kTXvU1armR

[Broad Institute @broadinstitute]

Using data from nearly 50,000 #COVID19 patients across 19 countries, scientists report 13 genetic factors strongly associated with #SARSCoV2 infection or severe COVID-19. Learn more: https://t.co/2mc1AysRQ9